CMHC News Archive
The Yale School of Public Health's Activist in Residence, Angelo Pinto, Assistant Professor Ijeoma Opara, several students and a postdoctoral researcher traveled to Jackson, Mississippi, in the wake of the city's water crisis and learned that the city's problems run much deeper.
- November 07, 2022
Does Street Outreach Engage Its Intended Target Population? Clinical Experience in the Veteran’s Health Administration Homeless Service ProgramsSource: Psychiatric Quarterly
Emma Lo, MD; Jack Tsai, PhD; Elina Stefanovics, PhD; and Robert Rosenheck, MD, are co-authors of a paper in Psychiatric Quarterly that found veterans engaged through clinical street outreach programs reported substantially more days of unsheltered homelessness than a clinic-referred group of veterans.
- October 31, 2022
As part of their work on an CCDF evaluation plan grant, PEER management team members are participating in the PROSPR community of practice, a network convened by ACF OPRE.
- October 31, 2022
The National Institutes of Health describes the Helping End Addiction Long-term (HEAL) Initiative as “an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis.” Initiated in 2018, the 2.5 billion-dollar initiative funds more than 1,000 projects across the country to advance understanding and treatment of opioid, other substance use disorders and pain. Among recent awardees are several core faculty members in the Yale Program in Addiction Medicine.
- October 26, 2022
The American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR) have issued an updated policy, with regarding the use of electronic nicotine delivery systems (ENDS). Roy S. Herbst, MD, PhD, is corresponding author on the statement published today in both Clinical Cancer Research and the Journal of Clinical Oncology.
- October 19, 2022
“You have to understand the community you serve.” New Haven’s director of public health, Maritza Bond, MPH, made this point during the two-part panel discussion series for the Yale health professional schools community, New Haven Voices, held on September 8 and 29.
- September 28, 2022
Newly Established IMPOWR-YOU Center Engages Diverse Partners to Guide Research Aiming to Advance Treatments for Chronic Pain and Opioid Use Disorder
The Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center, launched at Yale School of Medicine nearly one year ago with a transformative $11.8 million grant through the NIH Helping End Addiction Long-term (HEAL) initiative, is seeking to advance integrated treatments for individuals who experience the overlap of chronic pain and opioid use disorder (OUD) or opioid misuse.
- September 26, 2022
With a grant from Women's Health Research at Yale, Dr. Stuart Weinzimer, in collaboration with Drs. Thomas Carpenter and Christy Olezeski, is using sophisticated methods to obtain a picture of the dynamic process of bone development in adolescents undergoing gender-affirming hormone therapy.
- September 19, 2022
Matthew M. Burg, PhD, professor at the Yale School of Medicine and clinical psychologist, co-edited a special issue in the journal Health Psychology.
- September 15, 2022Source: CT Public
In late August, a JAMA Psychiatry article detailed the results of the largest-ever clinical trial of a drug called psilocybin, a psychedelic found in so-called “magic mushrooms.” The study found that a combination of psilocybin and talk therapy reduced drinking by 80% after eight months of therapy. To talk about this, Dr. Christopher Pittenger, a Yale School of Medicine professor and director of the Yale OCD Research Clinic, joined "All Things Considered." He says he’s not only encouraged by the study, but also by the interest Connecticut legislators have shown in one day making psilocybin therapy available to people it could help.